Illinois Tool Works Earnings Call Transcripts
Fiscal Year 2026
-
The meeting confirmed strong shareholder support for all board nominees and executive compensation, with a focus on sustained growth through innovation and disciplined capital allocation. Dividend increases and robust financial results were highlighted, while a shareholder proposal on director removal was not approved.
-
Q1 2026 saw 5% revenue growth and 12% GAAP EPS growth, with strong performance in CapEx-related segments and margin expansion to 25.4%. Full-year guidance was raised, with all segments expected to deliver positive organic growth and margin improvement.
Fiscal Year 2025
-
Q4 and full-year results showed strong revenue and margin growth, with all segments expanding margins and robust CBI-driven innovation. 2026 guidance projects continued organic growth, margin expansion, and high cash returns to shareholders, supported by ongoing investments and a strong innovation pipeline.
-
Q3 2025 saw revenue up 3% (1% organic), record operating income, and GAAP EPS of $2.81, with strong margin expansion and robust free cash flow. Guidance for full-year EPS was narrowed to $10.40–$10.50, reflecting confidence despite a choppy demand environment.
-
Q2 delivered record EPS and operating margin, with revenue up 1% and strong execution in China and automotive. Full-year guidance was raised, with all segments expected to grow and improve margins in H2, despite ongoing macro and tariff challenges.
-
Q1 delivered flat organic growth and $2.38 EPS, with strong margins and cash flow. Full-year guidance is unchanged, with tariff impacts expected to be EPS neutral or better, and sequential margin improvement anticipated across all segments.
Fiscal Year 2024
-
Record 2024 results with strong margin and cash flow growth, driven by enterprise initiatives and innovation. 2025 guidance projects continued margin expansion, solid free cash flow, and all segments targeting margin improvement despite currency and restructuring headwinds.
-
Third quarter results showed a 1% organic revenue decline amid moderating demand, but operating margin remained strong at 26.5% and EPS grew 4% excluding divestiture gains. Full-year EPS guidance was raised, and three segments achieved over 30% operating margin.
-
Q2 results showed flat organic revenue, record operating margin, and strong EPS growth despite moderating demand. Full-year guidance was revised to flat organic growth and slightly lower EPS, but margin guidance was raised. Enterprise initiatives and strategic repositioning in Specialty support long-term growth.